The U.S. Postal Service (USPS) has temporarily halted inbound parcel shipments from China and Hong Kong Posts starting February 4. However, letters and flat mail will continue to be accepted, according to the USPS website.
The agency has not confirmed whether this suspension is linked to former President Donald Trump's recent move to end 'de minimis' shipments from China and other nations. The de minimis rule allows duty-free imports valued under $800, benefiting e-commerce businesses. Nearly half of these shipments originate from China, according to a June 2023 U.S. congressional report.
Trump's plan includes a 10% tariff on Chinese goods and a 25% tariff on imports from Canada and Mexico, though these were temporarily paused for a month. The policy aims to curb reliance on low-cost imports and strengthen domestic manufacturing.
This change could disrupt e-commerce businesses relying on small, low-value shipments from China, including platforms such as Temu, Shein, and Alibaba. With USPS suspending parcels, businesses may seek alternative shipping methods, potentially increasing costs and delivery times.
While USPS has not provided a timeline for resuming parcel acceptance, industry experts predict significant disruptions to international shipping and cross-border trade. The situation remains dynamic as regulatory policies evolve.
This development highlights growing trade tensions and the shifting landscape of U.S.-China commerce, impacting consumers, retailers, and logistics providers alike.


U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 



